New study reveals unique metabolic function of lung-resident NK immune cells

Trinity College Dublin researchers, based at St James’s Hospital have provided important insights into the behavior and metabolic function of a previously largely unknown, but crucial ‘natural killer’ (NK) immune cell resident in the lungs.

Abiomed announces enrollment of first patient in landmark RECOVER IV trial for AMI cardiogenic shock

Abiomed, part of Johnson & Johnson MedTech, announces the first patient in the world has been enrolled in the landmark RECOVER IV randomized controlled trial

November 27, 2023

Long Covid is a new name for an old syndrome

Long Covid goes by many names. Today, it is no longer a new public health enigma, but the outlook for sufferers is no better than when the

September 14, 2023

Synaffix expands Innovent deal; Recipharm co-develops inhalers; VitriVax gets $5M for vaccine tech

Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls and more. Lonza-owned Synaffix boosted its licensing

December 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.